Cheap Indian Generic Weight-Loss Drugs Expected After Patent Expiry

India's patent for semaglutide is set to expire on March 20, leading to expectations that approximately 50 branded generic weight-loss drugs will enter the market.

Post Share

Sources

Showing 0 of 1 sources

No articles available in your preferred languages.

1 article available in other languages below.

danasSerbian18d ago

Jeftini indijski lekovi za mršavljenje u borbi protiv gojaznosti

Indijski patent za semaglutid ističe 20. marta, očekuje se da će na tržište ući oko 50 brendiranih generičkih lekova.

Read full article →

PERSPECTA

PERSPECTA

Cheap Indian Generic Weight-Loss Drugs Expected After Patent Expiry

Sources

Jeftini indijski lekovi za mršavljenje u borbi protiv gojaznosti

Related Stories

Amazon's First Customer Receipt Goes Viral, Bezos and Musk React

Marcos announces fuel price cuts, more government aid

Diesel to drop by P20.89/liter; gasoline, kerosene prices also down

Philippine transport board summons bus operator over Camarines Sur crash

PERSPECTA